Tag #Copycat Drugs

Showing 1 to 2 of 2 results

cbsnews.com
🌐 85% Global Worthiness
News related image

Novo Nordisk Shares Plunge on Lowered Profit Outlook Amidst Copycat Drug Competition

Novo Nordisk shares fell over 20% on Tuesday after the company announced a new CEO and lowered its profit expectations, citing weaker sales of its weight-loss drug Wegovy due to competition from copycat drugs; the company expects 8%-14% sales growth and 10%-16% operating profit growth for 2025.

Progress

44% Bias Score

Good Health and Well-being
dailymail.co.uk
🌐 85% Global Worthiness
News related image

Novo Nordisk Cuts Forecasts Amid Copycat Weight-Loss Drug Surge

Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, cut its sales and profit forecasts due to competition from copycat weight-loss drugs made by compounding pharmacies in the US, which captured about a third of the market despite a forthcoming ban and the company exceeding first...

Progress

40% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results